Inva Gen Pharmaceuticals, Inc. Avenue Therapeutics, Inc. (ATXI) insider trading activity

ATXI Quotes by TradingView

Inva Gen Pharmaceuticals, Inc. is > 10% Shareholder of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of ATXI, which is worth approximately $0. The most recent transaction as insider was on Oct 11, 2022, when has been sold 388,888 shares (Common Stock, par value $0.0001 per share) at a price of $7.71 per share, resulting in proceeds of $2,998,326. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

InvaGen Pharmaceuticals, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 11 2022
SELL
Open market or private sale
$2,998,326 $7.71 p/Share
388,888 Reduced 100.0%
0 Common Stock, par valu...
IPI

Inva Gen Pharmaceuticals, Inc.

> 10% Shareholder
Hauppauge, NY

Track Institutional and Insider Activities on ATXI

Follow AVENUE THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXI shares.

Notify only if

Insider Trading

Get notified when an Avenue Therapeutics, Inc. insider buys or sells ATXI shares.

Notify only if

News

Receive news related to AVENUE THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATXI